Summary
To study the influence of age on the kinetics of atrial natriuretic peptide (ANP) in man, human (99–126) ANP 2.0 μg·min−1 was infused IV for 60 min in 8 healthy young (18 to 25 y) and 9 healthy elderly (71 to 84 y) subjects.
Both baseline ANP values and the levels at the end of infusion were higher in the elderly subjects. The mean residence time of ANP in the two age groups was not significantly different, whereas total body clearance (CL) was markedly diminished in the elderly as compared to the young subjects (mean±SD 3.1±1.0 l·min−1 and 6.2±4.1 l·min−1, respectively). The apparent volume of distribution at steady state was lower in the elderly than in the young, but the difference was not significant (mean±SD 44±19 and 103±111, respectively. The decrease in CL largely explained the higher ANP levels found in the elderly subjects. The MRT and the plasma half-life of the terminal phase did not differ between the two groups.
In the elderly but not in the young subjects the calculated endogenous creatinine clearance was closely correlated with the CL (r=0.90, P<0.001), thereby emphasizing the importance of the kidney in the metabolic clearance of ANP in the elderly.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Goetz KL (1988) Physiology and pathophysiology of atrial peptides. Am J Physiol 254: E1-E15
Lang RE, Unger T, Ganten D (1987) Atrial natriuretic peptide: a new factor in blood pressure control. J Hypertension 5: 255–271
Gnädinger MP, Lang RE, Hasler L, Uehlinger DE, Shaw S, Weidmann P (1986) Plasma kinetics of synthetic alpha-human atrial natriuretic peptide in man. Min Electrolyte Metab 12: 371–374
Nakao K, Sugawara A, Morii N et al. (1986) The pharmacokinetics of α-human atrial natriuretic polypeptide in healthy subjects. Eur J Clin Pharmacol 31: 101–103
Yandle TG, Richards AM, Nicholls MG, Cuneo R, Espiner EA, Livesey JH (1986) Metabolic clearance rate and plasma half life of alpha-human atrial natriuretic peptide in man. Life Sci 38: 1827–1833
Ezaki H, Matsushita S, Shiraki M, Kuramoto K, Yamaji T (1988) Clinical evaluation of the plasma levels of immunoreactive atrial natriuretic peptide in elderly patients with heart diseases. J Am Geriatr Soc 36: 537–541
Haller BGD, Züst H, Shaw S, Gnädinger MP, Uehlinger DE, Weidmann P (1987) Effects of posture and ageing on circulating atrial natriuretic peptide levels in man. J Hypertension 5: 551–556
Rosmalen FMA, Tan ACITL, Tan HS, Benraad TJ (1987) A sensitive radioimmunoassay of atrial natriuretic peptide in human plasma, using a tracer with an immobilized glycouril agent. Clin Chim Acta 165: 331–340
Jansen TLThA, Tan ACITL, Smits P, de Boo TH, Benraad ThJ, Thien T (1990) Hemodynamic responses to atrial natriuretic factor in young and aged subjects. Clin Pharmacol Ther 48: 179–188
Cockroft DW, Gault MH (1976) Prediction of creatinine clearance from serum creatinine. Nephron 16: 31–41
Mosteller RD (1987) Simplified calculation of body surface area. N Engl J Med 317: 1098
Elseviers MM, VEropooten GA, De Broe ME, De Backer GG (1987) Interpretation of creatinine clearance. Lancet I: 457
Raine AEG, Erne P, Bürgisser E et al. (1986) Atrial natriuretic peptide and atrial pressure in patients with congestive heart failure. N Engl J Med 315: 533–537
Veng-Pedersen P (1989) Mean time parameters in pharmacokinetics. Clin Pharmacokinet 17: 345–366
Ohashi M, Fujio N, Nawata H, Kato K, Matsuo H, Ibayashi H (1987) Pharmacokinetics of synthetic α-human atrial natriuretic polypeptide in normal men: effect of aging. Regul Pept 19: 265–272
Poole S, Gaines Das RE, Dzau VJ, Richards AM, Robertson JIS (1988) The international standard for atrial natriuretic factor — calibration by an international collaborative study. Hypertension 12: 629–634
Richards AM, Tonolo G, McIntyre GD, Leckie BJ, Robertson JIS (1987) Radio-immunoassay for plasma alpha human atrial natriuretic peptide: a comparison of direct and pre-extracted methods. J Hypertension 5: 227–236
Berg JA, Hayashi M, Fujii Y, Katz AI (1988) Renal metabolism of atrial natriuretic peptide in the rat. Am J Physiol 255: F466-F473
Marumo F, Sakamoto H, Ando K, Ishigami T, Kawakami M (1986) A highly sensitive radioimmunoassay of atrial natriuretic peptide (ANP) in human plasma and urine. Biochem Biophys Res Commun 137: 231–236
Schulz-Knappe P, Forssmann K, Herbst F, Hock D, Pipkorn R, Forssmann WG (1988) Isolation and structural analysis of “urodilatin”, a new peptide of the cardiodilatin-(ANP)-family, extracted from human urine. Klin Wochenschr 66: 752–759
Crozier IG, Nicholls MG, Ikram H, Espiner EA, Yandle TG, Jans S (1986) Atrial natriuretic peptide in humans — production and clearance by various tissues. Hypertension 8 [Suppl II]: (II)11-(II)15
Luft FC, Lang RE, Aronoff GR et al. (1986) Atriopeptin III kinetics and pharmacodynamics in normal and anephric rats. J Pharmacol Exp Ther 236: 416–418
Hollister IS, Rodeheffer RJ, White FJ, Potts JR, Imada T, Inagami T (1989) Clearance of atrial natriuretic factor by lung, liver, and kidney in human subjects and the dog. J Clin Invest 83: 623–638
Maack T, Suzuki M, Almeida FA et al. (1987) Physiological role of silent receptors of atrial natriuretic factor. Science 238: 675–678
Anderson S, Brenner BM (1986) Effects of aging on the renal glomerulus. Am J Med 80: 435–442
Chai SY, Sexton PM, Allen AM, Figdor R, Mendelsohn FAO (1986) In vitro autoradiographic localization of ANP receptors in rat kidney and adrenal gland. Am J Physiol 250: F753-F757
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Tan, A.C.I.T.L., Jansen, T.L.A., Termond, E.F.S. et al. Kinetics of atrial natriuretic peptide in young and elderly subjects. Eur J Clin Pharmacol 42, 449–452 (1992). https://doi.org/10.1007/BF00280134
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00280134